In recent decades, cryotechnology has developed from a niche discipline into a mainstay of modern life sciences. And the pace of change is accelerating. New forms of therapy such as cell and gene therapies, the increasing automation of laboratory processes, a growing awareness of sustainability and the introduction of artificial intelligence into laboratory work are fundamentally changing the requirements for cryogenic systems.
As a company that has been at the forefront of cryotechnology for decades, Consarctic® is not just observing these developments - we are actively shaping them. In this article, we analyze the most important trends that will shape the cryo industry in 2026 and beyond.
The manual removal and storage of samples from and into cryogenic containers at -196°C is not only time-consuming, but also a safety risk for personnel. Automated storage systems - cryo robots that can store and retrieve samples independently - are one of the strongest trends in the industry.
AI and machine learning are finding their way into cryogenic storage. Algorithms are already being used to detect anomalies in temperature data, predict maintenance requirements and optimize the logistics of nitrogen supply.
Instead of reactively responding to alarms, an AI analyzes the trends in the sensor data (temperature curves, evaporation rates, fill level patterns) and warns before a problem even occurs. This increases operational reliability and reduces maintenance costs at the same time.
AI-based systems learn from historical consumption data and dynamically adjust the refill cycles of the automatic liquid nitrogen supply. Seasonal fluctuations, laboratory operating times and planned maintenance work are incorporated into the forecast.
Cryogenic technology is not energy-intensive per se - compared to ULT freezers (-80°C), a passive LN2 tank does not consume any electricity. Nevertheless, the industry has potential to improve its eco-balance.
The approval of more and more new CAR-T products, mRNA-based therapies and gene therapy approaches is driving the demand for high-quality cryopreservation exponentially. Every single therapy requires a flawless cold chain from the manufacturing laboratory to the patient's bedside.
For Consarctic®, this means increasing demand for GMP-compliant controlled rate freezers, validated dry shippers for international transportation and automated monitoring solutions.
The international standard ISO 20387 defines uniform requirements for the management and quality assurance of biobanks for the first time. Its increasing prevalence is driving the professionalization of the industry and increasing the need for validated, certified cryotechnology.
Cryotechnology is facing an exciting decade. Automation, AI, sustainability and new forms of therapy will change the industry more than any previous development. Consarctic® is continuously investing in the further development of its products and services to not only keep pace with this change, but to actively shape it.
Would you like to know how you can prepare your cryobank for the future? Contact our experts for strategic advice that thinks beyond today's needs and prepares you for tomorrow's requirements.